Delivery Order SPE2DB22D1017-SPE2DB25FF5PR
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,117.62, is a Firm Fixed Price Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG UU 30S, a type of pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $40,784.69 and has an ultimate completion date of January 29, 2025. The contract is for the supply of emtricitabine-tenofv 200-300mg medication to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,858.85 firm fixed-price contract is for the delivery of emtricitabine-tenofovir 200-300mg pharmaceutical products. The contract has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,153.24 Firm Fixed Price Delivery Order contract is for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of November 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,786.41, is a Delivery Order for the delivery of EMTRICITABINE-TENOFV 200-300MG medication. The contract has an ultimate completion date of June 3, 2024 and is a Firm Fixed Price contract. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,210.20, is a delivery order contract for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has a completion date of May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,058.82 and is for the delivery of EMTRICITABINE-TENOFV 200-300MG UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of January 30, 2025. There is no set-aside designation specified for this award. AmerisourceBergen holds...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,904.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the provision of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific delivery order has a ceiling...